Financial Health Assessment: A. Oppenheimer & Co. Limited

1. Financial Health Score: B+

Explanation: The company exhibits a robust constitution with a strong balance sheet and minimal debt, akin to a patient with excellent bone density and healthy blood pressure. However, there are symptoms of concern—specifically, declining profitability and a dividend policy that exceeds earnings, which is akin to living beyond one's means. The overall financial immune system is strong, but lifestyle adjustments are needed.

2. Key Vital Signs

Additional Vital Signs from Balance Sheet:

3. Diagnosis

What the Financial Data Reveals About Business Health

The Patient's Constitution: Fundamentally Strong

A. Oppenheimer & Co. Limited is a long-established business (incorporated 1948) with the financial equivalent of a strong skeleton and healthy cardiovascular system. The balance sheet shows net assets of nearly £4 million against total liabilities of just £440,444 (including provisions), representing a debt-to-equity ratio of approximately 0.11:1. This is the financial equivalent of having very low cholesterol—excellent long-term prospects for survival.

Symptom 1: Declining Profitability - A Slowing Pulse

The most concerning symptom is the trajectory of profits: - 2022 → 2023: £86,821 profit - 2023 → 2024: £57,544 profit (33.7% decline)

This decline in profitability, while the asset base remains substantial, suggests the business is experiencing margin compression or revenue challenges. Think of this as a patient whose heart rate is slowing—not immediately dangerous, but worth investigating the underlying cause.

Symptom 2: Unsustainable Dividend Policy - Bleeding Reserves

The company is paying £190,000 in annual dividends while generating only £57,544 in profit. This means: - Dividend payout ratio: 330% - Annual reserve depletion: £132,456

Over the past two years, P&L reserves have fallen from £2,823,196 to £2,616,459—a drawdown of £206,737. This is the financial equivalent of a patient losing more blood than their body can produce. While reserves are substantial (£2.6M), this cannot continue indefinitely without eventually weakening the patient.

Symptom 3: Heavy Inventory Concentration - Potential Blockage

Stock represents £1,135,405 or 55% of current assets. This is significant for a wholesale/retail business and represents capital tied up in warehouses. If inventory isn't turning efficiently, it's like having healthy blood cells that are sluggish and not delivering oxygen effectively.

Symptom 4: Asset Revaluation History - Hidden Strength

The significant jump in net assets from 2020 (£1.85M) to 2021 (£3.79M) appears driven by property revaluation, evidenced by the revaluation reserve of £1,035,660. The company holds £1,671,027 in tangible assets (likely including freehold property) and £846,832 in investments. This provides a substantial cushion but is not liquid.

Positive Signs: Excellent Liquidity and Minimal Debt

The current ratio of 5.66:1 means the company can comfortably meet all short-term obligations 5.6 times over. Total liabilities represent less than 10% of total assets. Cash, while declining, remains adequate at £182,421 for a company of this size.

4. Recommendations

Prescriptions for Financial Wellness

🔴 Urgent: Review Dividend Policy

The most critical intervention needed. The current dividend of £190,000 annually exceeds profit by approximately £132,000. Recommendations: - Reduce dividends to align with actual profitability (maximum £50,000-£57,000) - Consider suspending dividends for 1-2 years to allow reserves to rebuild - If dividends must continue for shareholder needs, explore whether the majority shareholder (Mr. Adler with 75%+ control) could receive compensation through alternative, more tax-efficient means

🟡 Important: Investigate Profit Decline

Diagnose the root cause of falling profits: - Is this margin compression from wholesale competition? - Are e-commerce operations (SIC 47910) underperforming? - Can pricing be adjusted or costs reduced? - What is the gross margin trend over the past 5 years?

🟡 Important: Optimise Inventory Management

With £1.135M in stock (55% of current assets): - Review stock turnover ratios by product category - Identify slow-moving or obsolete inventory for clearance - Consider just-in-time purchasing where possible - Target reducing stock by 15-20% to free up working capital

🟢 Beneficial: Accelerate Cash Collection

Trade debtors of £746,430 represent significant capital tied up: - Review credit terms offered to customers - Implement stricter collection procedures - Consider early payment incentives - Target reducing debtor days by 10-15 days

🟢 Beneficial: Strategic Review of Investment Portfolio

The company holds £846,832 in investments: - Review whether these are generating adequate returns - Consider whether capital could be better deployed in the core business - Ensure investment income is being maximised

🟢 Beneficial: Succession Planning

As a company incorporated in 1948 with a single dominant shareholder (Mr. Adler with 75%+ control), succession planning is essential: - Ensure business continuity provisions are in place - Consider the tax implications of future ownership transitions - Document key business relationships and processes

Prognosis

Short-term (1-2 years): Stable but deteriorating

The company's substantial asset base and minimal debt provide a strong buffer against immediate financial distress. However, if the current trajectory continues—declining profits combined with excessive dividend extraction—the financial health will gradually weaken.

Medium-term (3-5 years): Dependent on corrective action

If the dividend policy is corrected and profitability is restored, the prognosis is excellent given the strong balance sheet. Without correction, reserves will continue to erode, though the company has approximately 15-20 years of runway at current depletion rates before reaching critical levels.

Long-term (5+ years): Positive with intervention

The underlying asset value and established market position (76+ years in business) suggest strong fundamental viability. The key risk is not business failure, but gradual value extraction that leaves the company financially weaker over time.

Summary Comparison: Financial Health Trends